General Session
Date & Time:
March 24, 2025
8:00 AM – 9:30 AM ET
Format:
In Person & Virtual
CE Credits:
1.5 Hours
UAN: JA0002345-0000-25-043-L99-P
Course level:
Advanced
What You'll Learn
Since the days of the Seven Countries Study led by Dr. Ancel Keys, which demonstrated the link between dietary saturation fat intake and coronary heart disease, our focus in health care has been on the detrimental health effects of fat. However, recent developments have begun to change this negative connotation. The 2025 Dudrick Research Symposium will highlight cutting-edge research that is being performed in the realm of fatty acids, including the benefit of fish oil/omega-3 fatty acids, the clinical utility of specialized pro-resolving mediators, and the benefits and future potential for use of modified fatty acids in parenteral nutrition (PN) related complications.
LEARNING OBJECTIVES
- Summarize the impact of modified fatty acids in the prevention and treatment of PN related complications such as IFALD.
- Discuss the benefit of fish oil in general health and nutrition support.
- Outline the physiology of specialized pro-resolving mediators and their clinical utility.
Topics & Presenters
Benefit of Modified Fatty Acids
Professor of Surgery
Harvard Medical School
Attending Surgeon
Department of Surgery, Boston Children's Hospital
Is it Time for Bioactive Lipids, EPA and DHA to Take Center Stage in Nutritional Pharmacology Again?
Professor of Surgery
Division of Gastrointestinal and General Surgery, Oregon Health & Science University
Medical Director
Hospital Nutrition Services, Oregon Health & Science University
Insights Into the Biology of Specialized Pro-Resolving Mediators
Professor of Molecular Pharmacology
Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Lipid Mediator Unit Director
William Harvey Research Institute, Queen Mary University of London
Moderators:
Manpreet Mundi
MDProfessor of Medicine
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic